Kahan experiences serving as a advisor for Currax, Gelesis, Lilly and Vivus; serving on the board of administrators for American Board of Weight problems Medication, Weight problems Motion Coalition and The Weight problems Society; and receiving textbook royalties from Johns Hopkins College Press, Lippincott and Williams & Wilkins. Leffert experiences no related monetary disclosures.
SAN DIEGO — On this video unique, Jonathan D. Leffert, MD, talks with Scott Kahan, MD, MPH, about express and implicit weight bias, which might trigger physicians to deal with sufferers in another way due to their weight.
Leffert is managing associate at North Texas Endocrine Heart and previous president of AACE. He’s additionally an Endocrine As we speak Editorial Board Member. Kahan is director of the Nationwide Heart for Weight and Wellness, school member on the Johns Hopkins Bloomberg College of Public Well being.
Heavier sufferers obtain much less care and poorer high quality care, Kahan mentioned, and maybe counterintuitively, weight bias results in much less motivation to decide to a weight reduction routine and extra weight achieve.
“Solely about 1.5% of eligible sufferers get handled with an FDA-approved remedy for weight problems, and that not less than not directly is pushed by weight stigma,” Kahan mentioned.